NCT07194239 Life-Style Medicine for Chronic Musculoskeletal Pain in Older People
| NCT ID | NCT07194239 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Musculoskeletal |
| Study Type | INTERVENTIONAL |
| Enrollment | 268 participants |
| Start Date | 2025-02-09 |
| Primary Completion | 2027-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 268 participants in total. It began in 2025-02-09 with a primary completion date of 2027-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to determine the clinical effectiveness of lifestyle medicine in reducing chronic musculoskeletal pain in older adults, as measured by pain intensity, pain interference, self-management efficacy, stress level, sleep quality, healthier diet, better quality of life, and cost-effectiveness, compared to a waitlist control group. Participants will be randomly assigned to either the intervention or the waitlist group. The intervention group will meet the health coach face-to-face for four sessions to negotiate and set personalized health goals. The waitlist control group will continue to receive usual care without any additional intervention for 24 weeks. Both groups will complete three assessments: at the start of the study, one month after the intervention, and three months after the intervention. The waitlist control group will be offered the same intervention after completing the study.
Eligibility Criteria
Inclusion Criteria: * chronic musculoskeletal pain, defined as pain that lasted for more than 3 months persistently or intermittently, including regional pain (joints, limbs, back, and/or neck) * a degenerative joint condition, such as osteoarthritis, and/or musculoskeletal complaints that fall under the classification of the International Classification of Disease-11 as "chronic primary musculoskeletal pain" or "chronic secondary musculoskeletal pain" * Pain intensity score ≥ 4 on a numerical rating scale of 10 * stable baseline physical activity * ability to understand written and verbal Chinese Exclusion Criteria: * patient with cancer-related pain * inflammatory rheumatic disease * a recent history of stroke or major surgery in the past 6 months * terminal illness * serious mental illness * severe or uncontrolled heart disease * comorbid conditions that might impede active participation in the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07194239 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Musculoskeletal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07194239 currently recruiting?
Yes, NCT07194239 is actively recruiting participants. Contact the research team at cheryllcfung@cuhk.edu.hk for enrollment information.
Where is the NCT07194239 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT07194239 clinical trial?
NCT07194239 is sponsored by Chinese University of Hong Kong. The trial plans to enroll 268 participants.